Literature DB >> 4401963

Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man.

A H Beckett, J A Salmon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4401963     DOI： 10.1111/j.2042-7158.1972.tb08942.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  9 in total

1.  Derivation of general equations for linear mammillary models when the drug is administered by different routes.

Authors:  D P Vaughan; A Trainor
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  General pharmacokinetic equations for linear mammillary models with drug absorption into peripheral compartments.

Authors:  D P Vaughan; D J Mallard; A Trainor; M Mitchard
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

3.  General theory for rapidly establishing steady state drug concentrations using two consecutive constant rate intravenous infusions.

Authors:  D P Vaughan; G T Tucker
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

4.  Interactions of iprindole with fenfluramine metabolism in rat brain and liver.

Authors:  K M Hegadoren; G B Baker; R T Coutts; W G Dewhurst
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 5.  In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions.

Authors:  Parthena Martin; Maciej Czerwiński; Pallavi B Limaye; Seema Muranjan; Brian W Ogilvie; Steven Smith; Brooks Boyd
Journal:  Pharmacol Res Perspect       Date:  2022-06

Review 6.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

7.  Pharmacokinetics of fenfluramine enantiomers in man.

Authors:  S Caccia; M Ballabio; P De Ponte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

8.  The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.

Authors:  G Cheymol; J Weissenburger; J M Poirier; C Gellee
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

9.  Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days.

Authors:  S Caccia; I Conforti; J Duchier; S Garattini
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.